# Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

> **NCT02400359** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Obesity
- Weight Loss

## Interventions

- **DRUG:** Lorcaserin HCl
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02400359
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2014-10
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02400359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02400359, "Lorcaserin in Obesity: Identification of CNS Targets Using fMRI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02400359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*